Maybe there's just less longevity researchers. The absolute funding makes little difference from an individual career perspective–even if it does have a large e

Maybe there's just less longevity researchers. The absolute funding makes little difference from an individual career perspective–even if it does have a large effect on the field as a whole. I've linked to a page of academics from top institutions[0]. If you're at Harvard researching longevity, then you're doing OK career-wise, imho. If you sell your company for $720 million, you're doing OK career-wise, imo. Demonstrably, you're incorrect. [0] http://www.elysiumhealth.com/team http://www.elysiumhealth.com/team